Gemcite 1 gm Injection

Get a Price/Quote

Gemcite 1 gm Injection Specification

Origin of Medicine
Allopathic

Pacakaging (Quantity Per Box)
1 vial per box

Salt Composition
Gemcitabine Hydrochloride

Drug Type
Injection

Ingredients
Gemcitabine Hydrochloride 1 gm

Physical Form
Liquid

Function

Recommended For
Patients diagnosed with cancers such as non-small cell lung cancer pancreatic cancer and breast cancer

Dosage
1 gm per administration or as prescribed by the oncologist

Dosage Guidelines
Administered intravenously under the supervision of a healthcare professional; frequency and dosage depend on the type of cancer and patient-specific factors

Suitable For

Quantity
1 vial per unit

Storage Instructions
Store at 2°C to 8°C in a dry dark place; do not freeze

About Gemcite 1 gm Injection

Gemcite 1 gm Injection is a potent chemotherapy drug containing Gemcitabine Hydrochloride 1 gm. Designed for adults undergoing chemotherapy treatment, this allopathic medication inhibits DNA synthesis in cancer cells. Each box includes 1 vial of liquid form injection for intravenous administration as prescribed by an oncologist. Recommended for patients with non-small cell lung cancer, pancreatic cancer, and breast cancer, the dosage guidelines should be strictly followed. Store between 2C to 8C and do not freeze for optimal effectiveness.

FAQs of Gemcite 1 gm Injection:

Q: What is Gemcite 1 gm Injection used for?

A: Gemcite 1 gm Injection is used to treat various types of cancer by inhibiting DNA synthesis in cancer cells.

Q: How should Gemcite 1 gm Injection be stored?

A: It should be stored at 2C to 8C in a dry dark place; do not freeze.

Q: What is the dosage of Gemcite 1 gm Injection?

A: The recommended dosage is 1 gm per administration or as prescribed by the oncologist.

Q: Who is Gemcite 1 gm Injection suitable for?

A: It is suitable for adults undergoing chemotherapy treatment.

Q: What are the different types of cancer that Gemcite 1 gm Injection is recommended for?

A: Gemcite 1 gm Injection is recommended for patients diagnosed with cancers such as non-small cell lung cancer, pancreatic cancer, and breast cancer.

Tell us about your requirement